Mark Li
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Cancer Genomics and Diagnostics 3
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Douglas Labar (1 shared paper)Richard A. R. Fraser (1 shared paper)Syed A. Hosain (1 shared paper)Cynthia L. Harden (1 shared paper)Ling Yang (5 shared papers)Qingwen Qian (5 shared papers)Michael D. Pasquale (1 shared paper)Stanley J. Kurek (1 shared paper)
- Journals
- Translational Lung Cancer Research (2 papers)Gastroenterology (2 papers)PLoS ONE (2 papers)Cell Metabolism (2 papers)Lung Cancer (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Mark Li
30 papers receiving 1.3k citations
Mark Li's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 192
- Pulmonary and Respiratory Medicine 312
- Neurology 73
- Neurology 100
- Oncology 111
Countries citing papers authored by Mark Li
This map shows the geographic impact of Mark Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Li more than expected).
Fields of papers citing papers by Mark Li
This network shows the impact of papers produced by Mark Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Li. The network helps show where Mark Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diverse alterations associated with resistance to KRAS(G12C) inhibition Hit paper breakdown → | 2021 | 337 |
| 2 | 2019 | 142 | |
| 3 | 2004 | 105 | |
| 4 | 2000 | 103 | |
| 5 | 2018 | 103 | |
| 6 | 2020 | 83 | |
| 7 | 2006 | 78 | |
| 8 | 2007 | 63 | |
| 9 | 2014 | 44 | |
| 10 | 2021 | 42 | |
| 11 | 2021 | 29 | |
| 12 | 2019 | 26 | |
| 13 | 2017 | 24 | |
| 14 | 2021 | 23 | |
| 15 | 2012 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2012 | 18 | |
| 18 | 2024 | 17 | |
| 19 | 2020 | 16 | |
| 20 | 2021 | 15 |
About Mark Li
Mark Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Clinical Biochemistry, Genetics and Epidemiology, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Adipose Tissue and Metabolism (3 papers), Cancer Genomics and Diagnostics (3 papers), Inflammatory mediators and NSAID effects (2 papers), Mesenchymal stem cell research (2 papers), Mitochondrial Function and Pathology (2 papers), Congenital heart defects research (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Cancer Research (192 citations), Pulmonary and Respiratory Medicine (312 citations), Neurology (73 citations), Neurology (100 citations) and Oncology (111 citations). Mark Li has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Douglas Labar, Richard A. R. Fraser, Syed A. Hosain, Cynthia L. Harden, Ling Yang, Qingwen Qian, Michael D. Pasquale, Stanley J. Kurek, Zeyuan Zhang and Thomas Wasser. Their work appears in journals such as Translational Lung Cancer Research, Gastroenterology, PLoS ONE, Cell Metabolism and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.